INT280011

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.31
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 3.31
Pain Relevance 0.12

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleoplasm (NOLC1) mitosis (NOLC1) nucleolus (NOLC1)
nucleus (NOLC1) cell cycle (NOLC1) DNA binding (NOLC1)
NOLC1 (Homo sapiens)
Pain Link Frequency Relevance Heat
drug abuse 1 85.92 High High
methadone 2 75.92 Quite High
addiction 1 38.48 Quite Low
fibrosis 14 5.00 Very Low Very Low Very Low
Inflammation 8 5.00 Very Low Very Low Very Low
agonist 4 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
depression 2 5.00 Very Low Very Low Very Low
Paracetamol 2 5.00 Very Low Very Low Very Low
pruritus 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hepatitis C Virus Infection 290 100.00 Very High Very High Very High
Infection 190 99.96 Very High Very High Very High
Acquired Immune Deficiency Syndrome Or Hiv Infection 30 88.08 High High
Drug Dependence 1 85.92 High High
Hepatitis B Virus Infection 5 74.32 Quite High
Liver Disease 21 56.36 Quite High
Hepatitis 7 50.00 Quite Low
Carcinoma 1 32.72 Quite Low
Cirrhosis 17 32.20 Quite Low
Hepatocellular Cancer 12 29.00 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We, therefore, assessed the prevalence of HCV infection and associated risk behaviors among IDU upon intake to detention in Tehran, Iran.


Negative_regulation (prevalence) of HCV associated with hepatitis c virus infection and infection
1) Confidence 0.31 Published 2009 Journal J Urban Health Section Body Doc Link PMC2791818 Disease Relevance 1.47 Pain Relevance 0.12
HCV antiviral development involves all three of classes, HCV protease inhibitors (PIs), nucleoside HCV polymerase inhibitors (NIs), and nonnucleoside HCV polymerase inhibitors (NNIs).
Negative_regulation (inhibitors) of HCV associated with hepatitis c virus infection
2) Confidence 0.00 Published 2009 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2731021 Disease Relevance 0.90 Pain Relevance 0
HCV antiviral development involves all three of classes, HCV protease inhibitors (PIs), nucleoside HCV polymerase inhibitors (NIs), and nonnucleoside HCV polymerase inhibitors (NNIs).
Negative_regulation (inhibitors) of HCV associated with hepatitis c virus infection
3) Confidence 0.00 Published 2009 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2731021 Disease Relevance 0.94 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox